ATE1856T1 - Peptide mit ubiquitin-aehnlicher aktivitaet, verfahren zu ihrer herstellung, sie enthaltende therapeutische zusammensetzungen und ihrer anwendung. - Google Patents

Peptide mit ubiquitin-aehnlicher aktivitaet, verfahren zu ihrer herstellung, sie enthaltende therapeutische zusammensetzungen und ihrer anwendung.

Info

Publication number
ATE1856T1
ATE1856T1 AT80300771T AT80300771T ATE1856T1 AT E1856 T1 ATE1856 T1 AT E1856T1 AT 80300771 T AT80300771 T AT 80300771T AT 80300771 T AT80300771 T AT 80300771T AT E1856 T1 ATE1856 T1 AT E1856T1
Authority
AT
Austria
Prior art keywords
sub
peptides
activity
ubiquitin
therapeutic compositions
Prior art date
Application number
AT80300771T
Other languages
English (en)
Inventor
Gideon Goldstein
George Heavner
Original Assignee
Ortho Pharmaceutical Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Pharmaceutical Corporation filed Critical Ortho Pharmaceutical Corporation
Application granted granted Critical
Publication of ATE1856T1 publication Critical patent/ATE1856T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/66—Thymopoietins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06104—Dipeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT80300771T 1979-03-14 1980-03-13 Peptide mit ubiquitin-aehnlicher aktivitaet, verfahren zu ihrer herstellung, sie enthaltende therapeutische zusammensetzungen und ihrer anwendung. ATE1856T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/020,157 US4215111A (en) 1979-03-14 1979-03-14 Peptides having ubiquitin-like activity
EP80300771A EP0016612B1 (de) 1979-03-14 1980-03-13 Peptide mit Ubiquitin-ähnlicher Aktivität, Verfahren zu ihrer Herstellung, sie enthaltende therapeutische Zusammensetzungen und ihrer Anwendung

Publications (1)

Publication Number Publication Date
ATE1856T1 true ATE1856T1 (de) 1982-12-15

Family

ID=21797065

Family Applications (1)

Application Number Title Priority Date Filing Date
AT80300771T ATE1856T1 (de) 1979-03-14 1980-03-13 Peptide mit ubiquitin-aehnlicher aktivitaet, verfahren zu ihrer herstellung, sie enthaltende therapeutische zusammensetzungen und ihrer anwendung.

Country Status (18)

Country Link
US (1) US4215111A (de)
EP (1) EP0016612B1 (de)
JP (1) JPS55143946A (de)
AT (1) ATE1856T1 (de)
AU (1) AU544923B2 (de)
CA (1) CA1146166A (de)
DE (1) DE3061127D1 (de)
DK (1) DK149091C (de)
ES (1) ES489521A0 (de)
FI (1) FI67691C (de)
GR (1) GR68038B (de)
IE (1) IE49423B1 (de)
IL (1) IL59603A (de)
NO (1) NO149998C (de)
NZ (1) NZ193077A (de)
PT (1) PT70948B (de)
YU (1) YU41913B (de)
ZA (1) ZA801483B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4369137A (en) * 1980-06-17 1983-01-18 Ortho Pharmaceutical Corporation N-Protected pentapeptides useful as intermediates in the preparation of thymopoietin pentapeptide
US4298523A (en) * 1980-06-17 1981-11-03 Ortho Pharmaceutical Corporation Methods and compositions for preparation of H-ARG-X-Z-Y-TYR-R
US4289759A (en) * 1980-06-23 1981-09-15 Ortho Pharmaceutical Corporation Immunoregulatory diketopiperazine compounds
US4481191A (en) * 1983-03-30 1984-11-06 The Regents Of The University Of California Method for controlling blood pressure
AU602483B2 (en) * 1985-01-18 1990-10-18 Immunetech Pharmaceuticals Immunoregulatory peptides
JPH01104193A (ja) * 1986-06-10 1989-04-21 Kyowa Hakko Kogyo Co Ltd 新規ポリペプチド
US6258550B1 (en) 1993-04-23 2001-07-10 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site
US5952465A (en) * 1993-04-23 1999-09-14 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site
US5965698A (en) * 1993-04-23 1999-10-12 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein--protein interaction site
US5928896A (en) * 1993-04-23 1999-07-27 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein--protein interaction site
AU6770794A (en) * 1993-04-23 1994-11-21 Herbert J. Evans Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site
US6084066A (en) * 1993-10-29 2000-07-04 Virginia Commonwealth University Polypetides that include conformation-constraining groups which flank a protein-protein interaction site
US5770720A (en) * 1995-08-30 1998-06-23 Barnes-Jewish Hospital Ubiquitin conjugating enzymes having transcriptional repressor activity

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4113858A (en) * 1975-01-20 1978-09-12 St. Luke's Hospital Novel compounds, compositions and methods of their use
FR2391994A1 (fr) * 1977-05-25 1978-12-22 Anvar Nouveaux polypeptides a activite thymique ou a activite antagoniste et leurs procedes de synthese
SE446867B (sv) * 1977-11-15 1986-10-13 Sloan Kettering Inst Cancer Sett att framstella en polypeptid med formaga att inducera differentiering av t-lymfocyter men inte av komplementreceptor (cr?72+) b-lymfocyter
SE446866B (sv) * 1977-11-15 1986-10-13 Sloan Kettering Inst Cancer Sett att framstella en aktiv polypeptid med formaga att inducera differentiering av bade t-lymfocyter och komplementreceptor (cr?72+) b-lymfocyter
NZ189101A (en) * 1977-12-08 1984-07-06 Ortho Pharma Corp Polypeptides having the ability to induce differentiation of both th-1+ t-lymphocytes and bu-1+ b-lymphocytes;pharmaceutical compositions

Also Published As

Publication number Publication date
YU41913B (en) 1988-02-29
DK149091B (da) 1986-01-20
IE800515L (en) 1980-09-14
GR68038B (de) 1981-10-27
EP0016612A3 (en) 1981-01-07
DK109180A (da) 1980-09-15
PT70948B (en) 1981-06-24
EP0016612A2 (de) 1980-10-01
ZA801483B (en) 1981-10-28
AU5631380A (en) 1980-09-18
FI67691B (fi) 1985-01-31
CA1146166A (en) 1983-05-10
ES8103026A1 (es) 1981-02-16
EP0016612B1 (de) 1982-11-24
IL59603A0 (en) 1980-06-30
NO149998C (no) 1984-08-01
IE49423B1 (en) 1985-10-02
DK149091C (da) 1986-06-16
PT70948A (en) 1980-04-01
IL59603A (en) 1983-02-23
FI67691C (fi) 1985-05-10
YU65980A (en) 1984-02-29
ES489521A0 (es) 1981-02-16
NO149998B (no) 1984-04-24
NZ193077A (en) 1984-05-31
US4215111A (en) 1980-07-29
NO800724L (no) 1980-09-15
JPH0153268B2 (de) 1989-11-13
DE3061127D1 (en) 1982-12-30
AU544923B2 (en) 1985-06-20
FI800779A (fi) 1980-09-15
JPS55143946A (en) 1980-11-10

Similar Documents

Publication Publication Date Title
EG12374A (en) Process for preparing of novel substituted n-phenyl-n'benzoyl-ureas and their use as insecticides
GR60789B (en) Preparation process of 2,4-dichlor-4'-benzoylureido-diphenylether and use thereof as insecticides
ATE1856T1 (de) Peptide mit ubiquitin-aehnlicher aktivitaet, verfahren zu ihrer herstellung, sie enthaltende therapeutische zusammensetzungen und ihrer anwendung.
AU2124177A (en) The use of cyclic carbonic acid esters as solvents for poly-(b-hydroxy butric acid
ATE56728T1 (de) Neue polypeptide mit alpha-amylase-hemmender wirkung, verfahren zu deren herstellung, deren verwendung und pharmazeutische praeparate.
ATE880T1 (de) 6 beta.7 beta; 15.16-dime thylen-1.4-androstadien-3-one, verfahren zu ihrer herstellung und verwendung als arzneimittel.
GR59825B (en) Preparation process of n-(3-trifluormethyl-4-halogen-phenyl)-n'-urea and their use as insecticides
ES8101530A1 (es) Un procedimiento para la preparacion de alcoholes beta-gama-dihidro-poliprenilicos.
GR60791B (en) 2',3',6'-trichlor-4-cyano-4'-benzoylureido-diphenylether,preparation process and use thereof as insecticides
ES8106304A1 (es) Un procedimiento para la preparacion de fenil-quinolicidinas
DE3162181D1 (en) Hexapeptides, their manufacture, their use in medicaments and compositions containing them
IT1067271B (it) Catalizzatori,procedimento per la loro preparazione,e loro applicazione alla trasformazione di cariche d'idrocarburi
AT344885B (de) Verfahren zur herstellung von 18-arabinosyl-2-n-butyl-3,7,11,15,19,21,23,25,27,37-dekahydroxy-4,16,32,34,36-pentamethyl-tetrakonta-16,32-dien-35-o-lacton-40-guanidiniumsulfat(debrycin) enthaltenden pharmazeutischen praeparaten
ES475345A1 (es) Un procedimiento para la preparacion de diclorovinilciclobu-tanonas
ES8100661A1 (es) Un procedimiento para la preparacion de 1-(3-bromo-isoxa- zol-5-il)-2-tercibutilaminoetanol
IL49208A (en) 13,14-dehydro-16-fluoro prostanoic acid derivatives of the f2,a2 and e2 series,process for their preparation and pharmaceutical compositions containing same
JPS53130693A (en) Antibiotic substance c-15003
ATE18408T1 (de) 11beta-chlor-delta15-steroide, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
PT70584A (en) Process of synthesis for the preparation of substituted 2-phenylamino-imidazoline-(2)with particular pharmaceutical properties
IT1101727B (it) Nuove 2-fenilammino-imidazoline-(2) sostituite, dotate di particolari proprieta' terapeutiche, loro processo di sintesi e composizioni farmaceutiche
ATE15197T1 (de) Neue diglycidyl-pteridin-verbindungen, verfahren zu ihrer herstellung und ihre anwendung in arzneimitteln mit cytostatischer wirkung.
BE878812A (fr) Nouveaux amides secondaires d'acides 2-alcynoiques, leur preparation et leur application comme medicaments

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee